Skip to main content

Pre-Surgery Planning MRI Report 7/16/2023

The surgery was performed on 7/17/2023.

******

MR BRAINNAV WITH AND WITHOUT CONTRAST DTI:  7/16/2023 10:00 AM

INDICATION (as provided by referring clinician): Presurgical Planning

ADDITIONAL HISTORY: metastatic melanoma to the lung and brain with prior recurrence, s/p multiple resections and radiation for brain metastases (last completed stereotactic radiation in the right temporal horn on 10/12/2022). Currently on Nivolumab maintenance with an Ipilimumab "booster" every 6 months. The first day of q 6 month ipiwasadded to Cycle 5 nivo on 5/3/23.

COMPARISON: MRI brain 7/1/2023.

TECHNIQUE: Multiple sequences through the brain were acquired at 3.0 tesla.

MEDICATIONS:

Dotarem - 16.4 mL - Intravenous

FINDINGS:

Postsurgical changes following prior right temporal and left parieto-occipital craniotomy. Compared to MRI of 7/1/2023, overall increased size of multiple areas of nodular enhancement throughout the bilateral supratentorial brain. For example, subependymal nodule along the posterior left intraventricular septum measures 1.2 x 0.6 cm (11:88) compared to 1.0 x 0.4 cm previously, subependymal enhancement along the left temporal horn measures 1.8 x 1.1 cm (11:49) compared to 1.5 x 0.9 cm previously, and newly apparent subependymal enhancement along the left frontal horn (11:79). Enhancement along the margins of the left occipital resection cavity and right temporal horn appear similar to minimally increased. Areas of enhancement demonstrate associated reduced diffusion, increased perfusion and surrounding T2/FLAIR hyperintensity, particularly along the left occipital resection cavity. Similar extent of associated mass effect without midline shift or herniation.

Additional nonenhancing foci of T2/FLAIR hyperintensity in the bilateral periventricular and deep white matter are nonspecific but unchanged. No acute infarct or hemorrhage. 

The ventricles remain similar in size and configuration. No hydrocephalus. No extra-axial collection.

Unchanged small bilateral mastoid effusions.

IMPRESSION: 

MRI obtained for presurgical planning.

1.  Compared to 7/1/2023, evidence of progression with increased nodular enhancement along the left parieto-occipital resection cavity and bilateral subependymal surfaces. No midline shift, herniation or hydrocephalus.

Comments

Popular posts from this blog

2nd talk with Surgeon

Found out more about the VATS procedure today. They'll remove a nodule, and then keep me on the table while it's biopsied. If it is positive, they'll get more material, then wrap up. If the biopsy comes back negative, they'll do another nodule... and biopsy again and wait... not sure how many times they'll repeat. I guess I'm hoping for a long procedure. The surgeon said he'll ask the lab to freeze some of the material so that I could have it retrieved at a later time... mentioned I was getting a second opinion from UCSF cancer center, and that UCSF may therefore be interested in getting some of the sample as well.

Cyberknife 11/9-10

Underwent 2 cyberknife sessions, the first to treat the tumor bed of the first brain tumor, the second to treat the second one that showed up recently. The procedure is pretty straightforward, it's outpatient. The picture shows the mask they made for me which holds my head in place so the laser is accurate. Each session was an hour or so. I should know by the end of the weekend if there are any short-term complications (none I hope). Then it's a matter of letting the radiation do its job over the next couple of months. Then re-scanning to see both how the two treated areas are doing, and also to see if anything new shows up in the brain.

Cycle 4/Course 2 Finished

(8/6-8/9/2010) Finished cycle 4/course 2. Stopped this time due to some combination of high white T cell count, neurotoxicity and maybe something else. Tolerated 4 bags out of a total of 14, felt as bad as the other times where I tolerated more doses. Will get more scans in about 5 weeks time, and see what they look like compared to the last sets.